Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zsolt Barta

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Inflammatory Bowel Diseases|October 31, 2008
Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohortPeter Laszlo Lakatos, Istvan Altorjay, Tamas Szamosi, et al.
Clinical Chemistry|February 9, 2008
Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestationsMaria Papp, Ildiko Foldi, Eva Nemes, et al.
BMC Gastroenterology|September 11, 2009
Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational studyPál Miheller, Péter L Lakatos, Gábor Horváth, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Inflammatory Bowel Diseases|October 31, 2008
Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohortPeter Laszlo Lakatos, Istvan Altorjay, Tamas Szamosi, et al.
Clinical Chemistry|February 9, 2008
Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestationsMaria Papp, Ildiko Foldi, Eva Nemes, et al.
BMC Gastroenterology|September 11, 2009
Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational studyPál Miheller, Péter L Lakatos, Gábor Horváth, et al.
Pageof 5